{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:59:40Z","timestamp":1791237580693,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.clim.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:59Z","timestamp":1504569659000},"page":"34-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Variable domain glycosylation of ACPA-IgG: A missing link in the maturation of the ACPA response?"],"prefix":"10.1016","volume":"186","author":[{"given":"Ayla C.","family":"Kempers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Hafkenscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-5617","authenticated-orcid":false,"given":"Hans Ulrich","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.09.001_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2017.09.001_bb0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2017.09.001_bb0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0463.2007.apm_682a.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. 1939","volume":"115","author":"Waaler","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.clim.2017.09.001_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0025","first-page":"1937","article-title":"Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor","volume":"213","author":"Tan","year":"2016"},{"key":"10.1016\/j.clim.2017.09.001_bb0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00002281-200405000-00013","article-title":"Rheumatoid factor revisited","volume":"16","author":"Dorner","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2017.09.001_bb0035","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.09.001_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.09.001_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0050","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.09.001_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.23148","article-title":"Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis","volume":"58","author":"van Oosterhout","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0065","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0070","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrrheum.2015.59","article-title":"Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens","volume":"11","author":"Koning","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2017.09.001_bb0080","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.09.001_bb0085","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.09.001_bb0095","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0100","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","article-title":"Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/annrheumdis-2013-203947","article-title":"Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins","volume":"74","author":"Hensvold","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.001_bb0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.09.001_bb0115","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/acr.22385","article-title":"Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population","volume":"66","author":"Terao","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2017.09.001_bb0120","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/art.23763","article-title":"Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease","volume":"58","author":"Ioan-Facsinay","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0125","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.001_bb0130","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","article-title":"Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis","volume":"63","author":"van de Stadt","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2010.135509","article-title":"Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens","volume":"70","author":"Suwannalai","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.001_bb0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20121486","article-title":"Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition","volume":"210","author":"Amara","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.09.001_bb0145","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/kes371","article-title":"Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns","volume":"52","author":"van de Stadt","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2017.09.001_bb0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2010.131102","article-title":"Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities","volume":"70","author":"Ioan-Facsinay","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.001_bb0155","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-2836(02)01250-0","article-title":"Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity","volume":"325","author":"Krapp","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.clim.2017.09.001_bb0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0161-5890(00)00105-X","article-title":"The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms","volume":"37","author":"Mimura","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2017.09.001_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2017.09.001_bb0170","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/art.27414","article-title":"Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid","volume":"62","author":"Scherer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.001_bb0175","doi-asserted-by":"crossref","first-page":"e113924","DOI":"10.1371\/journal.pone.0113924","article-title":"IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence","volume":"9","author":"Lundstrom","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.09.001_bb0180","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","author":"Rombouts","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.001_bb0185","first-page":"1435","article-title":"The emerging importance of IgG Fab Glycosylation in immunity","volume":"196","author":"van de Bovenkamp","year":"2016"},{"key":"10.1016\/j.clim.2017.09.001_bb0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0161-5890(00)00038-9","article-title":"Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions","volume":"37","author":"Dunn-Walters","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2017.09.001_bb0195","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.09.001_bb0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.2003.04064.x","article-title":"Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma","volume":"120","author":"Zhu","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"Pt 2","key":"10.1016\/j.clim.2017.09.001_bb0205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj3140621","article-title":"Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients","volume":"314","author":"Youings","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2017.09.001_bb0210","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","author":"Rombouts","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.001_bb0215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1074\/mcp.M116.062919","article-title":"Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans","volume":"16","author":"Hafkenscheid","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.clim.2017.09.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211533","article-title":"The extensive glycosylation of the ACPA variable domain observed for ACPA-IgG is absent from ACPA-IgM","author":"Kempers","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.001_bb0225","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.09.001_bb0230","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood-2015-04-640805","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617305971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617305971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T23:50:24Z","timestamp":1535413824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617305971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"alternative-id":["S1521661617305971"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.09.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable domain glycosylation of ACPA-IgG: A missing link in the maturation of the ACPA response?","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}